What does a BIRADS 3 finding on a thyroid ultrasound mean and what is the recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

BI-RADS 3 Classification Does Not Apply to Thyroid Ultrasound

BI-RADS (Breast Imaging Reporting and Data System) is a classification system exclusively designed for breast imaging and should never be used for thyroid ultrasound evaluation. 1

Correct Thyroid Nodule Classification System

For thyroid nodules, you must use TI-RADS (Thyroid Imaging Reporting and Data System), not BI-RADS:

TI-RADS 3 (Mildly Suspicious) Management

For TI-RADS 3 thyroid nodules:

  • Fine needle aspiration (FNA) is recommended only if the nodule measures ≥1.5 cm 2
  • For nodules <1.5 cm classified as TI-RADS 3, surveillance without FNA is appropriate when high-risk clinical factors are absent 3
  • Follow-up ultrasound should be performed in 6-12 months for smaller TI-RADS 3 nodules 2

Initial Workup Algorithm

When evaluating any thyroid nodule:

  1. Obtain dedicated high-resolution thyroid ultrasound with central neck evaluation 3
  2. Measure TSH to assess thyroid function 3, 4
  3. Apply complete TI-RADS risk stratification assessing composition (solid vs cystic), echogenicity, margins, shape, and calcification patterns 4

High-Risk Clinical Factors That Lower FNA Threshold

Consider FNA for nodules <1.5 cm if any of these are present: 3

  • History of head and neck irradiation
  • Family history of thyroid cancer
  • Age <15 years
  • Male gender
  • Suspicious cervical lymphadenopathy

Critical Pitfall to Avoid

Do not confuse BI-RADS (breast) with TI-RADS (thyroid) - these are completely separate classification systems for different organs. BI-RADS category 3 indicates "probably benign" breast findings with <2% malignancy risk requiring short-term breast imaging follow-up 1, but this terminology and framework do not translate to thyroid evaluation.

References

Research

Understanding BI-RADS Category 3.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2025

Guideline

Management of Thyroid Nodules and Pulmonary Findings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Incidental Thyroid Abnormality on Ultrasound

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Thyroid Nodule Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.